Cold Gensys raises $22 mln
Cold Gensys Inc said March 18 that it raised $22 million in a Series C round led by ORI Healthcare Fund LP. Perseverance Capital Management participated in the round. Cold Genesys is a clinical-stage biopharmaceutical company focused on the development of immunotherapies.
18 March 2019•2 mins read
